Publications by the researcher in collaboration with Celia Pilar Martínez Jiménez (7)

2007

  1. Transcriptional regulation and expression of CYP3A4 in hepatocytes

    Current Drug Metabolism, Vol. 8, Núm. 2, pp. 185-194

2006

  1. Hepatocyte cell lines: Their use, scope and limitations in drug metabolism studies

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Núm. 2, pp. 183-212

  2. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4α requires coactivators peroxisomal proliferator activated receptor-γ coactivator 1α and steroid receptor coactivator 1

    Molecular Pharmacology, Vol. 70, Núm. 5, pp. 1681-1692

  3. Underexpressed coactivators PGC1α and SRC1 impair hepatocyte nuclear factor 4α function and promote dedifferentiation in human hepatoma cells

    Journal of Biological Chemistry, Vol. 281, Núm. 40, pp. 29840-29849

2005

  1. Species-specific mechanisms for cholesterol 7α-hydroxylase (CYP7A1) regulation by drugs and bile acids

    Archives of Biochemistry and Biophysics, Vol. 434, Núm. 1 SPEC. ISS., pp. 75-85

  2. Transcriptional regulation of the human hepatic CYP3A4: Identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein β isoforms (liver activating protein and liver inhibitory protein)

    Molecular Pharmacology, Vol. 67, Núm. 6, pp. 2088-2101

2004

  1. Can hepatoma cell lines be redifferentiated to be used in drug metabolism studies?

    ATLA Alternatives to Laboratory Animals